# 迷幻蘑菇市场

> 迷幻蘑菇市场研究报告按产品类型（干蘑菇、蘑菇提取物、药丸和胶囊、饮料）、按应用（医疗用途、娱乐用途、研究与开发）、按配方（天然、合成）、按分销渠道（在线零售、药店、专卖店）、按消费者年龄组（18-24岁、25-34岁、35-44岁、45岁及以上）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年。

- **Forecast Period:** 2025 - 2035
- **CAGR:** 38.42%
- **2024:** $ 0.72 Billion
- **2025:** $ 0.99 Billion
- **2035:** $ 25.6 Billion
- **Key Players:** Compass Pathways (GB), MindMed (CA), Field Trip Health (CA), Atai Life Sciences (DE), Silo Wellness (CA), Havn Life Sciences (CA), Mydecine Innovations Group (CA), Numinus Wellness (CA)

**Report ID:** MRFR/FnB/30552-HCR · **Pages:** 128 · **Author:** Snehal Singh · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/psychedelic-mushroom-market-32345

---

## Market Summary

## **Global****Psychedelic Mushroom Market Overview**

Psychedelic Mushroom Market Size was estimated at 0.27 (USD Billion) in 2022.The Psychedelic Mushroom Market Industry is expected to grow from 0.37(USD Billion) in 2023 to 6.85 (USD Billion) by 2032. The Psychedelic Mushroom Market CAGR (growth rate) is expected to be around 38.42% during the forecast period (2024 - 2032).

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Key Psychedelic Mushroom Market Trends Highlighted**

The Psychedelic [Mushroom](../../../reports/edible-mushroom-market-4351) Market is being driven by several key factors, including increasing acceptance of psychedelic substances for therapeutic purposes, particularly in mental health treatment. As research continues to unveil the potential of compounds like psilocybin in alleviating conditions such as depression, anxiety, and PTSD, more healthcare practitioners and institutions are integrating these substances into their therapeutic frameworks. This paradigm shift towards understanding and utilizing psychedelics in clinical settings is actively supported by changing regulations and decriminalization efforts in various regions, enhancing market accessibility and fostering innovation.

Opportunities within the market are vast, especially as public awareness grows about the mental health crisis and the limitations of traditional therapies. Companies focusing on research and development are well-positioned to capture a significant share of this market by creating new formulations or delivery methods that enhance the efficacy and safety of psychedelic treatments. Collaborations between biotech firms and academic institutions are set to pave the way for pioneering clinical trials, which can assure stakeholders of the legitimacy and practicality of treatments, further solidifying market trust.

Recent trends indicate a surge in investment and interest in psychedelic research, with numerous startups emerging to explore various applications beyond mental health, such as in addiction treatment, pain management, and even the enhancement of creativity. This evolving ecosystem is characterized by a blend of traditional approaches and innovative methodologies, contributing to a progressive narrative. As the stigma surrounding psychedelics diminishes, the market is likely to see increased participation from investors, researchers, and consumers, ultimately enhancing the diversity of products and services available in the psychedelic mushroom sector.

## **Psychedelic Mushroom Market Drivers**

### **Growing Acceptance of Psychedelics in Therapeutic Applications**

The increasing acceptance of psychedelic substances, particularly mushrooms containing psilocybin, for therapeutic applications is a major driver for the Psychedelic Mushroom Market Industry. Research and clinical trials have highlighted the potential of these substances to treat various mental health disorders, including depression, anxiety, PTSD, and addiction. This shift in perception from viewing psychedelics solely as recreational drugs to recognizing their medicinal properties has spurred interest and investment in the psychedelic space.As more studies demonstrate their efficacy and safety, regulatory bodies are more likely to approve these substances for clinical use, further driving the growth of the market.

Additionally, a growing body of anecdotal evidence supports the benefits of psychedelics in enhancing creativity, emotional openness, and overall well-being. This acceptance not only broadens the potential user base but also attracts various stakeholders, from pharmaceutical companies to wellness resorts, who are exploring ways to incorporate psychedelic mushrooms into their offerings.Consequently, the aim of integrating these substances into mainstream medicine and wellness practices positions the Psychedelic Mushroom Market Industry for significant growth. Furthermore, the emerging trend of microdosing consuming smaller, non-hallucinogenic doses of psychedelics to boost productivity and creativity adds another dimension to the market.

As more individuals and practitioners advocate for and engage in these practices, the demand for psychedelic mushrooms continues to rise, solidifying their place within the health and wellness landscape.

### **Increasing Research and Development Activities**

The surge in research and development activities surrounding psychedelic mushrooms plays a pivotal role in the expansion of the Psychedelic Mushroom Market Industry. Universities and research institutions are actively conducting studies to explore the therapeutic applications and effects of psilocybin. These R efforts not only enhance the understanding of psychedelics but also pave the way for innovative treatment methodologies. The more substantial scientific backing generated through research leads to increased trust and interest from medical professionals and patients alike.As result-oriented studies yield positive outcomes, opportunities for commercialization of psychedelic products grow, propelling the market forward substantially.

### **Rising Mental Health Awareness**

The heightened awareness and dialogue surrounding mental health issues are significantly driving the Psychedelic Mushroom Market Industry. As society recognizes the importance of mental well-being and the limitations of conventional treatments, alternative therapies, including those provided by psychedelic mushrooms, are gaining traction. This shift has resulted in more individuals seeking innovative solutions for their mental health struggles.The stigma surrounding mental health is gradually diminishing, leading to more discussions and openness about seeking help. Consequently, a larger demographic is exploring options like psychedelic therapy, contributing to the growing market.

## **Psychedelic Mushroom Market Segment Insights**

### **Psychedelic Mushroom Market Product Type Insights**

The Psychedelic Mushroom Market is poised for substantial growth, with its product type segmentation revealing vital insights into its development trajectory. This growth is partly attributed to the increasing acceptance of psychedelic substances for therapeutic uses. Among the diverse product types, Dried Mushrooms are particularly noteworthy, starting with a valuation of 0.15 USD billion in 2023 and projected to reach 2.79 USD billion by 2032, showcasing a strong demand base. This category is considered a majority holding in the market, largely due to the traditional use of dried mushrooms in various cultural settings, and their increasing popularity in therapeutic practices.

Mushroom Extracts also play a pivotal role in market dynamics. Valued at 0.1 USD billion in 2023, this segment is expected to escalate to 2.04 USD billion by 2032. The rise of mushroom extracts can be linked to their versatility in formulations and the growing trend of integrating functional ingredients into health products, which is compelling manufacturers to explore innovative extraction methods. Pills Capsules present a significant segment as well, beginning at 0.07 USD billion in 2023 and anticipated to increase to 1.42 USD billion in 2032.

This formulation format appeals to consumers seeking convenient and precise dosing of psilocybin, consolidating its importance in the market.Lastly, the Beverages segment, while currently valued at 0.05 USD billion in 2023, is projected to advance to 0.8 USD billion by 2032. This category is gradually gaining traction as consumers show interest in infused beverages that offer an alternative way to consume psychedelic compounds, reflecting broader trends in the beverage industry toward functional and wellness-oriented drinks.

The market segmentation indicates that each product type plays a distinct role, with Dried Mushrooms dominating due to cultural and therapeutic usage, while Mushroom Extracts are driving innovation in formulation. Pills Capsules cater to consumer convenience, and Beverages represent an emerging opportunity with innovative potential. The varied dynamics across these segments underscore the Psychedelic Mushroom Market's evolving landscape, fueled by changing consumer preferences and growing acceptance of psychedelics in mainstream health and wellness.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Psychedelic Mushroom Market Application Insights**

The Psychedelic Mushroom Market revenue has exhibited significant growth potential, driven by multiple applications within the industry. In 2023, the market was valued at 0.37 billion USD, highlighting a burgeoning interest in its application across various sectors. The application landscape encompasses Medical Use, Recreational Use, and Research & Development, with each area contributing distinct value to the overall market.

Medical Use has garnered attention for its therapeutic potential, particularly in treating mental health conditions, which is a strong growth driver due to the increased acceptance of psychedelics in healthcare.Recreational Use, characterized by growing consumer interest in recreational experiences, reflects a cultural shift toward the normalization of psychedelics, further bolstering market growth. Research & Development plays a critical role, driving innovation and expanding understanding in the field, making it a major contributing factor to advancements in psychedelic science.

As the market continues to evolve, these segments are poised to reshape the perceptions and applications of psychedelic mushrooms, offering new opportunities for growth and advancement in various industries over the coming years.

### **Psychedelic Mushroom Market Formulation Insights**

The Psychedelic Mushroom Market, in terms of formulation, is expected to reach a value of 0.37 billion USD in 2023, showcasing a rapid growth trajectory. This segment is fundamentally divided into natural and synthetic formulations, both of which play crucial roles in the market. Natural formulations are increasingly favored for their organic origins and perceived benefits, catering to a growing consumer preference for holistic and natural health solutions.

Meanwhile, synthetic formulations are recognized for their ability to offer consistency and controlled effects, thus appealing to therapeutic applications in clinical settings.With the overall market projected to reach 6.85 billion USD by 2032, the segmentation of the Psychedelic Mushroom Market highlights the dynamic interplay between these two formulation types. This interplay is driven by trends in mental health awareness and the exploration of psychedelics in therapy, creating opportunities for growth. Furthermore, the rising acceptance of psychedelics in mainstream medicine reflects a significant shift, countering past stigmas and opening doors for both natural and synthetic formulations to thrive.

Overall, the Psychedelic Mushroom Market segmentation provides critical insight into the evolving landscape, characterized by an increasing demand for safe, effective, and innovative formulations.

### **Psychedelic Mushroom Market Distribution Channel Insights**

The Psychedelic Mushroom Market, valued at 0.37 billion USD in 2023, showcases significant growth potential through its Distribution Channel segment. This market is characterized by various channels that cater to consumer preferences, including Online Retail, Pharmacies, and Specialty Stores. Online Retail is gaining traction due to the convenience and wider accessibility it offers, appealing to a tech-savvy clientele. Pharmacies play a crucial role as trusted sources for health-related products, reinforcing consumer confidence in the purchasing process.Specialty Stores often provide a curated experience, catering to those seeking more knowledge and focused products around psychedelic mushrooms.

Each distribution channel contributes uniquely to the market landscape, with sales from online platforms increasingly dominating overall market revenue. The Psychedelic Mushroom Market data indicates a strong trend towards e-commerce, aligning with the growing acceptance of psychedelic substances for therapeutic use, driven by increasing consumer awareness and advocacy for mental health. Furthermore, with a rising interest in alternative therapies, these channels are expected to evolve, presenting both challenges and opportunities for growth as regulatory landscapes change.Through these dynamics, the segmentation within the Psychedelic Mushroom Market reflects broader trends within the industry as it adapts to consumer needs and preferences.

### **Psychedelic Mushroom Market Consumer Age Group Insights**

The Psychedelic Mushroom Market revenue is experiencing notable growth, driven by a broadening acceptance of psychedelic substances, particularly among different consumer age groups. In 2023, the market was valued at 0.37 billion USD, with projections indicating a significant increase in the coming years. The data reveals a shifting demographic trend, with younger consumers (ages 18-34) showing a heightened interest in psychedelic mushrooms for therapeutic and recreational purposes.

This age group is pivotal, representing a majority holding within the market due to their openness to mental health alternatives and wellness trends.Meanwhile, individuals aged 35-44 are also becoming increasingly engaged, recognizing the benefits of psychedelics in dealing with stress and mental health issues, which contributes to their growing influence on the Psychedelic Mushroom Market segmentation. Conversely, the 45 and above demographic presents a contrasting dynamic, often more cautious yet curious about mental wellness solutions, driven largely by societal changes and evolving attitudes towards mental health.

Understanding these facets of age group segmentation is crucial as it shapes market strategies and innovation across the Psychedelic Mushroom Market industry.

### **Psychedelic Mushroom Market Regional Insights**

The Psychedelic Mushroom Market shows substantial growth potential across various regions, valued collectively at 0.37 USD Billion in 2023. North America currently dominates the market, with a valuation of 0.15 USD Billion, expected to surge to 2.8 USD Billion by 2032, showcasing its majority holding in the industry due to increasing acceptance and research activities.

Europe follows suit with a significant presence, rising from 0.1 USD Billion in 2023 to 1.5 USD Billion in 2032, underscoring growing interest in therapeutic and recreational uses of psychedelic mushrooms.In Asia Pacific, the market is valued at 0.05 USD Billion in 2023, projected to reach 1.0 USD Billion by 2032, indicating a rising trend driven by changing regulations and cultural shifts.

The Middle East and Africa (MEA) and South America, while smaller players at 0.04 USD Billion and 0.03 USD Billion, respectively, in 2023, are anticipated to expand to 0.8 USD Billion and 0.75 USD Billion by 2032, as these regions explore the potential benefits of psychedelics for mental health and wellness. Overall, the Psychedelic Mushroom Market data highlights a vibrant and rapidly growing industry across different regions, fueled by evolving perceptions and increasing demand for therapeutic solutions.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Psychedelic Mushroom Market Key Players And Competitive Insights**

The Psychedelic Mushroom Market is gaining noteworthy traction, driven by increasing recognition of the potential therapeutic benefits associated with psilocybin and other psychoactive compounds found in mushrooms. This market is characterized by a blend of established pharmaceutical companies, emerging startups, and research institutions that are fostering innovation in treatments for mental health disorders such as depression, anxiety, and PTSD. Competitive players are actively pursuing research and development endeavors, regulatory approvals, and partnerships to position themselves as leaders in a rapidly evolving ecosystem.

The landscape is marked by collaborations among various stakeholders, including growers, manufacturers, and healthcare providers, highlighting the importance of a strategic approach amid shifting regulatory frameworks that vary significantly across regions.Cresco Labs is well-positioned in the Psychedelic Mushroom Market due to its robust cultivation and distribution strategies that leverage its extensive experience in the cannabis sector. The company has established a solid foundation in regulated markets, offering high-quality products that appeal to both medical and recreational consumers. Cresco Labs capitalizes on its established brand reputation and strong market presence, allowing it to effectively navigate the complexities of this emerging sector.

Their strategic focus on product innovation, combined with commitment to education and consumer engagement, enhances their capacity to penetrate diverse market segments. With a strong operational infrastructure and an innovative pipeline, Cresco Labs is equipped to take advantage of the growing demand for psychedelic therapies.In the Psychedelic Mushroom Market, Curaleaf stands out with its commitment to bringing accessible and safe psychedelic solutions to consumers. Curaleaf is recognized for its comprehensive approach, encompassing cultivation, processing, and retail, which allows it to maintain a strong competitive edge.

The company's focus on research and development underscores its ambition to pioneer new treatments based on psychedelic compounds. Curaleaf's dedication to compliance and sustainability further reinforces its position within this rapidly changing market landscape. Leveraging its operational expertise, extensive distribution network, and strong brand identity, Curaleaf is actively expanding its footprint, demonstrating a keen understanding of consumer needs and regulatory dynamics in the evolving psychedelic space.

### **Key Companies in the Psychedelic Mushroom Market Include**

### Psychedelic Mushroom Market Industry Developments

- **Q2 2025: Psychedelics Market Update: H1 2025 in Review** Cybin reported new strategic partnerships with Osmind and Thermo Fisher Scientific, as well as new patents for its CYB003 and CYB004 programs. The company also announced promising Phase 2 efficacy data for CYB003 in major depressive disorder and ongoing Phase 2 studies for CYB004 in generalized anxiety disorder.
- **Q2 2025: Psychedelics Market Update: H1 2025 in Review** COMPASS Pathways announced on June 23, 2025, that its COMP360 psilocybin treatment successfully met its primary goal in a Phase 3 trial for treatment-resistant depression.
- **Q2 2025: Colorado's magic mushroom industry prepares to open its doors** At the end of March 2025, Colorado state regulators approved the first healing center license for a psychedelic mushroom facility in Denver, followed by the licensing of a cultivator and a healing center in Fort Collins.
- **Q3 2024: After an FDA rejection, here's what's next in the psychedelics pipeline** In August 2024, Cybin completed a meeting with the FDA to finalize the design of a Phase 3 study for its psilocybin-related drug CYB003, with the study slated to begin in late summer 2024.
- **Q4 2024: What 2025 could bring for psychedelic use in healthcare** Compass Pathways laid off 30% of its workforce in October 2024 to reorganize its business and focus solely on psilocybin therapy.

## **Psychedelic Mushroom Market Segmentation Insights**

### **Psychedelic Mushroom Market Product Type Outlook**

### **Psychedelic Mushroom Market Application Outlook**

### **Psychedelic Mushroom Market Formulation Outlook**

### **Psychedelic Mushroom Market Distribution Channel Outlook**

### **Psychedelic Mushroom Market Consumer Age Group Outlook**

### **Psychedelic Mushroom Market Regional Outlook**

## Market Drivers

### 临床研究的进展

临床研究的进展正在推动迷幻蘑菇市场进入一个新的理解和应用时代。最近的研究提供了有力的证据，支持了裸盖菇素的治疗益处，特别是在治疗各种心理健康状况方面。这些发现不仅增强了迷幻药物的科学可信度，还为监管批准和主流接受铺平了道路。随着研究方法的改进和更多严格试验的进行，迷幻蘑菇市场可能会看到经过验证的治疗选择的激增，这可能会显著扩大其市场覆盖范围和影响力。

### 法律环境的变化

围绕迷幻药的法律环境不断演变，是影响迷幻蘑菇市场的一个关键因素。多个司法管辖区开始为治疗目的非刑事化或合法化使用裸盖菇素。这一政策的转变可能会为迷幻蘑菇的研究、开发和商业化创造一个更有利的环境。例如，最近在各个地区的立法变化允许进行临床试验，并建立了迷幻药在治疗中使用的监管框架。随着更多地区采纳进步政策，迷幻蘑菇市场可能会见证加速增长，患者寻求替代治疗的可及性也将增加。

### 文化向替代疗法的转变

对替代疗法的文化态度正在发生变化，这对迷幻蘑菇市场产生了积极影响。越来越多的人接受非传统治疗方式，尤其是在年轻人群体中，他们更愿意探索迷幻药作为个人成长和疗愈的手段。这种文化转变反映在越来越受欢迎的健康度假和工作坊中，这些活动融入了迷幻体验。随着社会规范的演变，迷幻蘑菇市场可能会受益于更广泛的消费者基础，这些消费者寻求整体的心理健康和福祉方法，可能导致市场渗透率的提高。

### 增加对迷幻药研究的投资

对迷幻药物研究的投资是迷幻蘑菇市场的重要驱动力。众多风险投资公司和制药公司正在投入大量资金探索迷幻药物的治疗用途。这一资金的涌入正在促进先进的研究与开发，可能会导致对迷幻蘑菇的新应用的发现。截至2025年，迷幻药物研究的总投资 reportedly 超过了10亿美元，表明对理解这些物质的治疗潜力的强大承诺。这一财政支持不仅加快了研究的步伐，还增强了迷幻蘑菇市场的可信度，吸引了利益相关者的进一步关注。

### 对心理健康解决方案的关注日益增加

迷幻蘑菇市场因心理健康障碍的日益普遍而经历显著的兴趣激增。研究表明，抑郁症、焦虑症和创伤后应激障碍等疾病正变得越来越普遍，这促使人们寻找替代治疗方案。含有裸盖菇素的迷幻蘑菇在临床试验中显示出希望，表明它们在缓解与这些障碍相关的症状方面具有潜在的疗效。随着心理健康意识的提高，对创新治疗选择的需求可能会扩大，从而推动迷幻蘑菇市场的发展。此外，预计该市场在未来几年将实现超过15%的年复合增长率（CAGR），反映出对有效心理健康解决方案的迫切需求。

## Future Outlook

迷幻蘑菇市场预计将在2024年至2035年间以38.42%的复合年增长率增长，推动因素包括日益增加的治疗应用、监管变化以及消费者对心理健康解决方案的兴趣。

**New opportunities:**

- 专有蘑菇种植技术的开发

到2035年，市场预计将成为替代疗法的领先领域。

## Segment Insights

### 按类型：干蘑菇（最大）与蘑菇提取物（增长最快）

迷幻蘑菇市场在其各个细分领域中呈现出多样化的分布。干蘑菇占据了最大的市场份额，吸引了偏好传统消费方式的消费者。然而，蘑菇提取物正在迅速获得关注，特别是在寻求更强效和浓缩剂量的消费者中。其他细分市场如胶囊和饮料也为市场多样性做出了贡献，但其份额相对较小，主要集中在便利性和新颖的消费体验上。

迷幻蘑菇市场的增长趋势受到对心理健康治疗和迷幻药潜在治疗益处日益关注的推动。蘑菇提取物的兴起与消费者对更高效和多样性的偏好相吻合，促使产品配方的创新。同时，干蘑菇由于其既有的市场地位和文化接受度而继续蓬勃发展，表明随着健康趋势和科学研究的推进，该细分市场的未来前景乐观。

干蘑菇：主流与胶囊：新兴

干蘑菇主导着迷幻蘑菇市场，吸引着重视其真实本质的传统主义者和爱好者。这个细分市场吸引了那些欣赏以干燥形式消费蘑菇的整体体验的消费者。另一方面，胶囊药丸代表了一种新兴的市场趋势，旨在为那些寻求更方便和标准化消费形式的人设计。它们吸引了优先考虑剂量精确性和使用便利性的个人。虽然干蘑菇保持着传统根基，但胶囊药丸正将自己定位为现代生活方式的合适替代品，表明随着两个细分市场在市场中共同演变，消费者偏好正在逐渐转变。

### 按应用：医疗用途（最大）与娱乐用途（增长最快）

在迷幻蘑菇市场中，应用细分明显分为医疗用途、娱乐用途和研究与开发。目前，医疗用途占据市场最大份额，主要受到对迷幻药在治疗背景下的日益认可的推动，尤其是针对抑郁症和创伤后应激障碍等心理健康疾病。虽然娱乐用途较小，但随着公众观念的转变和各地区的非刑事化，需求迅速增长。研究与开发在支持这两个细分市场中发挥着至关重要的作用，提供有关迷幻化合物的有效性和安全性的见解。

医疗用途（主导）与娱乐用途（新兴）

迷幻蘑菇市场的医疗用途部分以其主导地位为特征，强调对治疗益处的严格研究以及在科学界日益增长的接受度。该部分强调迷幻药在治疗各种精神疾病方面的潜力，获得了医疗专业人士和投资者的强有力支持。相反，休闲用途正在显著崛起，受到文化变迁和心理健康意识提升的推动。该部分的特点是一个多样化的消费者群体，寻求迷幻体验以获得休闲享受和个人探索。随着社会态度的不断演变，这两个部分有望进一步交织，提供独特的体验和治疗进展。

### 按配方：天然（最大）与合成（增长最快）

迷幻蘑菇市场在配方方面展现出动态的格局，其中天然部分因其传统使用和文化接受度而占据重要份额。由于其被认为的最低风险和整体益处，这一部分在消费者中广受欢迎。同时，合成配方正在获得关注，特别吸引寻求精确迷幻化合物的实验室和研究人员。

配方：天然（主导）与合成（新兴）

迷幻蘑菇市场中的天然配方以其有机来源为特征，通常源自如Psilocybe cubensis等物种。这些产品在越来越多重视真实性和整体疗愈的消费者中获得了认可。相比之下，合成部分代表了一个蓬勃发展的领域，迎合了对迷幻药物更科学和受控的方法。合成替代品因其在确保剂量一致性和针对性效果方面的潜力而引起关注，从而将自己定位为未来迷幻疗法和探索中的重要参与者。

### 按分销渠道：在线零售（最大）与专业商店（增长最快）

在迷幻蘑菇市场中，分销格局主要由在线零售主导，捕获了市场份额的显著部分。这一增长可归因于各个地区对迷幻蘑菇的接受度和合法化的不断提高，推动了消费者需求和便利性。专业商店正在迅速增加其存在，吸引寻求特定产品专业知识和量身定制客户服务的细分市场。

零售渠道：在线（主导）与专业（新兴）

在线零售正逐渐成为迷幻蘑菇分销的主导力量，因其广泛的覆盖面和消费者便利性。电子商务的兴起使消费者能够以隐秘的方式购买产品，增强了可及性。相反，专业商店作为重要参与者正在崛起，提供精心挑选的产品和知识渊博的员工，以满足日益增长的消费者对迷幻体验的兴趣。随着法规的演变，专业商店可能会吸引忠实的客户群体，他们寻求个性化的建议和优质的产品，从而将自己定位为在线渠道的重要替代品。

### 按消费者年龄组：25-34岁（最大）与18-24岁（增长最快）

在迷幻蘑菇市场中，25-34岁年龄段是最大的消费人群，占据了市场份额的显著部分。该人群对迷幻体验和心理健康意识的开放程度显著较高。相反，18-24岁年龄段显示出快速增长，表明围绕迷幻药物的文化认知正在发生变化，这一变化受到社交媒体描绘和新兴研究强调其治疗益处的推动。

25-34： （主导）对比 18-24 （新兴）

25-34岁年龄段以对健康和个人成长的强烈偏好为特征，积极寻求市场中的迷幻选择。他们的消费通常与整体疗愈和自我发现相关。相比之下，18-24岁年龄段由于对迷幻药物态度的变化而成为一个重要的细分市场，这种变化受到更大信息获取和在线倡导讨论的推动。这个人群更具实验性，渴望探索替代体验，使他们成为未来迷幻蘑菇市场趋势营销的关键焦点。

## Regional Market Share Analysis

### 北美：开创性迷幻药研究

北美是迷幻蘑菇最大的市场，约占全球市场份额的60%。该地区的增长受到对迷幻药在治疗用途上日益接受的推动，特别是在心理健康治疗方面。监管变化，例如在几个州对裸盖菇素的非刑事化，进一步催化了市场扩张。对创新心理健康解决方案的需求也在上升，促进了该地区的强劲增长。

美国和加拿大是该市场的领先国家，竞争格局中有MindMed和Compass Pathways等关键参与者。众多专注于研究和开发的初创公司和成熟企业的存在正在促进创新。此外，学术机构与私营公司之间的合作正在增强北美公司在迷幻药领域的竞争优势。

### 欧洲：新兴市场动态

欧洲正在迅速崛起，成为迷幻蘑菇市场的重要参与者，约占全球市场份额的25%。该地区的增长受到对迷幻药治疗益处的研究增加以及公众认知转变的推动。德国和荷兰等国处于前沿，拥有支持临床试验和研究计划的进步监管框架。欧洲药品管理局也在探索迷幻物质的批准途径，这可能进一步加速市场增长。

德国在这一领域处于领先地位，越来越多的公司专注于迷幻药的研究和开发。竞争格局中包括Atai Life Sciences和Field Trip Health等公司，它们积极参与临床试验。公共机构与私营企业之间的合作正在促进创新，使欧洲成为迷幻蘑菇领域的关键参与者。

### 亚太地区：对迷幻药的日益关注

亚太地区对迷幻蘑菇市场的关注日益增长，约占全球市场份额的10%。这种增长受到对心理健康问题认识的提高以及迷幻药在治疗中潜在益处的推动。澳大利亚和新西兰等国走在前列，正在进行关于可能促进研究和治疗用途的监管变化的讨论。该地区对迷幻药的文化态度正在演变，为市场增长创造了更有利的环境。

澳大利亚处于前沿，几家公司正在探索迷幻药的研究和开发。竞争格局由初创公司和成熟企业的混合特征构成，专注于心理健康的创新解决方案。研究机构与私营公司的合作变得越来越普遍，增强了该地区在迷幻药领域的潜力。随着监管框架的演变，预计市场将在未来几年显著扩展。

### 中东和非洲：未开发的市场潜力

中东和非洲地区目前处于迷幻蘑菇市场的初期阶段，约占全球市场份额的5%。增长潜力显著，受到对替代疗法和心理健康解决方案日益关注的推动。然而，监管框架仍然限制，限制了研究和开发的机会。南非等国开始探索迷幻药的治疗益处，这可能为未来市场扩张铺平道路。

南非正在崛起为关键参与者，少数公司开始专注于迷幻药研究。竞争格局仍在发展中，与其他地区相比，参与者有限。然而，来自本地和国际投资者的日益关注正在促进一个更有利于创新的环境。随着对迷幻药的认识和接受度提高，该地区可能会逐渐向更支持的监管和市场增长转变。

## Competitive Benchmarking

迷幻蘑菇市场目前的特点是竞争格局动态，受到对心理健康治疗和迷幻药物治疗潜力日益增长的兴趣驱动。关键参与者如Compass Pathways（英国）、MindMed（加拿大）和Atai Life Sciences（德国）通过创新和合作伙伴关系战略性地定位自己。Compass Pathways（英国）专注于开发用于治疗耐药性抑郁症的迷幻蘑菇疗法，而MindMed（加拿大）则在推进其对焦虑和成瘾的迷幻药物研究。Atai Life Sciences（德国）采取多元化的方法，投资于各种迷幻化合物，并与生物技术公司建立合作，从而塑造一个强调研究和开发的竞争环境。

市场结构似乎适度分散，众多参与者争夺市场份额。公司越来越多地本地化生产并优化供应链，以提高效率并降低成本。这种竞争结构允许多种商业策略，因为公司寻求通过独特的产品提供和战略合作来区分自己。这些关键参与者的集体影响力显著，因为他们推动创新并设定行业标准，这可能导致未来市场的进一步整合。

2025年8月，Compass Pathways（英国）宣布与一家领先的心理健康组织建立合作伙伴关系，以扩大其临床试验网络。这一战略举措可能增强其研究能力，加速其迷幻蘑菇疗法的开发，使公司在治疗领域中处于领先地位。这种合作也可能促进更广泛患者群体的接触，从而增加成功结果和市场渗透的潜力。

2025年9月，MindMed（加拿大）推出了一个新的数字平台，旨在将迷幻疗法与远程医疗服务整合。这一举措反映了医疗保健数字化的日益趋势，表明MindMed（加拿大）希望提高患者的可及性和参与度。通过利用技术，该公司可能改善治疗依从性和结果，这可能在不断发展的市场环境中提供竞争优势。

2025年7月，Atai Life Sciences（德国）完成了一项对一家专注于新型迷幻化合物的生物技术公司的重大收购。这项收购表明Atai致力于扩展其产品管道并多样化其治疗产品。通过整合新技术和专业知识，Atai Life Sciences（德国）可能增强其市场地位，提高其应对各种心理健康问题的能力。

截至2025年10月，迷幻蘑菇市场的当前竞争趋势包括对数字化、可持续性以及在研究和开发中整合人工智能的明显关注。战略联盟越来越多地塑造着市场格局，因为公司认识到合作在推动创新中的价值。展望未来，竞争差异化可能会演变，从基于价格的竞争转向关注技术进步、创新疗法和可靠的供应链。这一转变可能重新定义市场动态，强调以研究为驱动的战略和可持续实践的重要性。

## Recent News & Developments

- **2025年第二季度：迷幻药市场更新：2025年上半年的回顾** Cybin报告了与Osmind和Thermo Fisher Scientific的新战略合作伙伴关系，以及其CYB003和CYB004项目的新专利。该公司还宣布了CYB003在重度抑郁症中的有希望的第二阶段疗效数据，以及正在进行的CYB004在广泛性焦虑症中的第二阶段研究。
- **2025年第二季度：迷幻药市场更新：2025年上半年的回顾** COMPASS Pathways于2025年6月23日宣布，其COMP360迷幻蘑菇治疗在针对耐药性抑郁症的第三阶段试验中成功达到了主要目标。
- **2025年第二季度：科罗拉多州的魔法蘑菇产业准备开门迎客** 在2025年3月底，科罗拉多州监管机构批准了丹佛市第一个迷幻蘑菇设施的治疗中心许可证，随后在福特柯林斯市批准了一家种植者和一家治疗中心的许可证。
- **2024年第三季度：在FDA拒绝后，迷幻药管道的下一步是什么** 在2024年8月，Cybin与FDA完成了一次会议，以最终确定其与迷幻蘑菇相关的药物CYB003的第三阶段研究设计，该研究计划于2024年夏末开始。
- **2024年第四季度：2025年对医疗保健中迷幻药使用的展望** Compass Pathways在2024年10月裁员30%以重组其业务，专注于迷幻蘑菇治疗。

## Report Scope

| 2024年市场规模 | 0.7161（十亿美元） |
| --- | --- |
| 2025年市场规模 | 0.9913（十亿美元） |
| 2035年市场规模 | 25.6（十亿美元） |
| 复合年增长率（CAGR） | 38.42%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 关键公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 关键市场机会 | 新兴的治疗应用和不断变化的法规为迷幻蘑菇市场创造了增长机会。 |
| 关键市场动态 | 消费者对治疗应用的兴趣上升推动了迷幻蘑菇市场的创新和监管变化。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 截至2024年，迷幻蘑菇市场的当前估值是多少？**
A: 2024年整体市场估值为7.161亿美元。

**Q: 到2035年，迷幻蘑菇市场的预计市场规模是多少？**
A: 预计2035年的估值为256亿美元。

**Q: 在2025年至2035年的预测期内，迷幻蘑菇市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，迷幻蘑菇市场的预期CAGR为38.42%。

**Q: 2024年，迷幻蘑菇市场哪个细分领域的估值最高？**
A: 干蘑菇细分市场在2024年的估值最高，达到2.861亿美元。

**Q: 蘑菇提取物的市场与药丸和胶囊的市场相比如何？**
A: 在2024年，蘑菇提取物和胶囊药丸的估值均为1.43亿美元。

**Q: 推动迷幻蘑菇市场的主要应用是什么？**
A: 主要应用包括医疗用途为2.861亿美元，娱乐用途为2.16亿美元，以及研究与开发为2.14亿美元。

**Q: 在迷幻蘑菇市场中，最突出的分销渠道是什么？**
A: 专业商店的估值为3.211亿美元，其次是在线零售2.15亿美元和药店1.8亿美元。

**Q: 在迷幻蘑菇市场中，哪个年龄组代表最大的消费群体？**
A: 25-34岁年龄组代表了最大的消费群体，估值为2.15亿美元。

**Q: 在迷幻蘑菇市场上有哪些配方可供选择？**
A: 市场包括价值4.291亿美元的天然配方和价值2.87亿美元的合成配方。

**Q: 迷幻蘑菇市场的关键参与者是谁？**
A: 主要参与者包括 Compass Pathways、MindMed、Field Trip Health、Atai Life Sciences、Silo Wellness、Havn Life Sciences、Mydecine Innovations Group 和 Numinus Wellness。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/psychedelic-mushroom-market-32345*